|
1. Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem 2009; 78:119-46. doi.10.1146/annurev.biochem.78.082907.145923 2. Li XZ, Plesiat P, Nikaido H. The challenge of efflux mediated antibiotic resistance in Gram negative bacteria. Clin Microbiol Rev 2015; 28:337-418. doi. 10.1128/CMR.00117-14 3. Richardson LA. Understanding and overcoming antibiotic resistance. PLos Biol2017; 15: 2003775. doi.10.1371/journal.pbio.2003775. 4. Summer GJ, Puntillo KA, Miaskowski C, Green PG, Levine JD. Burn injury pain the continuing challenge. J Pai 2007; 8:533-48. doi.10.1016/ j.jpain.2007.02.426. 5. Rosenkranz KM, Sheridan R. Management of the burned trauma patient balancing conflicting priorities. Burns 2002; 28:665-9. doi.10.1016/ s0305-4179(02)00109-2. 6. Hawkins A, Maclennan PA, Mcgwin JRG, Cross JM, Rue LW. The impact of combined trauma and burns on patient mortality. J Trauma 2005; 58:284-8. doi.10.1097/01.ta.0000130610.19361. bd. 7. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14:244-69. doi.10.1128/CMR.14.2.244-269.2001. 8. Loccarrillo C, Wu S, Beck JP. Phage therapy of wounds and related purulent infections. 1th ed. Cambridge USA CAB Int Publication. 2012; P.185-202. 9. Centers for disease control and prevention. Antibiotic antimicrobial resistance. 2 th ed. CDC Gov Drug Publication. 2017; P.1-100. 10. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev 2006; 19:403-34. doi.10.1128/CMR.19.2.403-434.2006. 11. Mayhall CG. The epidemiology of burn wound infections then and now. Clin Infect Dis 2003; 37543-50. doi.10.1086/376993. 12. Rafla K, Tredget EE. Infection control in the burn unit. Burns 2011; 37:5-15. doi. 10.1016/j.burns. 13. Azzopardi EA, Azzopardi E, Camilleri L, Villapalos J, Boyce DE, Dziewulski P, et al. Gram negative wound infection in hospitalised adult burn patients systematic review and metanalysis. Plos One 2014; 9:95042. doi.10.1371/journal.pone.0095042. 14. Norbury W, Herndon DN, Tanksley J, Jeschke MG, Finnerty CC. Infection in Burns. Surg Inf 2016; 17:250-5. doi.10.1089/sur.2013.134. 15. Chan Benjamin K, Abedonstephen T, Loccarrillo C. Phage cocktails and the future of phage therapy. Future Microbiol2013; 8:769-83. doi.10.2217/ fmb.13.47. 16. Doss J, Culbertson K, Hahn D, Camacho J, Barekzi N. A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms. Viruses 2017; 9:50. doi.10.3390/v9030050 17. Rahimzadehtorabi L, Doudi M, Noori A. [Antibacterial effects of gold nanoparticles on multi sdrug resistant Klebsiella pneumoniae and Escherichia coli and Its effect on the liver of balb/c Mice]. JSSU2016; 23:1001-17. (Persian) 18. Goli HR, Nahaei MR, Ahangarzadehrezaee M. Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals Iran. Iran J Microbiol 2016; 8:62-9. 19. Weisburg WG, Barns SM, Pelletier DA et al. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991; 173:697-703. doi.10.1128/ jb.173.2.697-703.1991. 20. Naghavi NS, Golgoljam M, Akbari, M. Effect of three sewage isolated bacteriophages on the multi drug resistant pathogenic bacteria. J Biol Sci 2013. doi.10.3923/jbs.2013.422.426 21. Ghasemi SM, Bouzari M, Emtiazi G. Preliminary characterization of Lactococcus garvieae bacteriophage isolated from wastewater as a potential agent for biological control of lactococcosis in aquaculture. Aquacult Int 2014; 22:1469-80. doi.10.1007/s00705-014-2142-z. 22. Rahimzadehtorabi L, Doudi M, Naghavi N, Monajemi R. Isolation characterization, and effectiveness of bacteriophage against XDR Acinetobacter baumannii isolated from nosocomial burn wound infection. Iranian J Bas Med Sci 2021; 24: 1254-63. doi.10.22038/ijbms.2021.57772.12850. 23. Mendes JJ, Leandro C, Cortereal S. Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Rep Reg 2013; 21:595-603. doi.10.1111/wrr.12056. 24. Rahimzadeh Torabi L, Doudi M, Naghavi N, Monajemi R. Bacteriophages pen-cl and pen-ho can eliminate MDR Enterobacter cloacae and Enterobacter hormaechei isolated from burn wound infections without toxicity for human skin cells. FEMS Microbiol Let 2021; 368: 143. doi.10.1093/femsle/fnab143. 25. Rahimzadehtorabi L, Naghavi NS, Doudi M, Monajemi R. Efficacious antibacterial potency of novel bacteriophages against ESBL producing Klebsiella pneumoniae isolated from burn wound infections. Iran J Microbiol 2021; 13:678-690. doi.10.18502/ijm. v13i5.7435. 26. Shokri D, Soleimani DA, Moayednia R, Mobasherizadeh S, Shirsalimian M, Enayatollahi S, et al. Isolation identification and evaluation of two lytic Bacteriophages against clinical antibiotic-resistant strains of Pseudomonas aeruginosa from waste water and hospital sewage of Isfahan city. Sci J Ilam Uni Med Scie 2015; 23:164-1172. 27. Zare L, Shenagari M, Khan Mirzaei MA, Mojtahedi A. Isolation of lytic phages against pathogenic E. coli isolated from diabtic ulcers. Iran J Med Microbiol 2017; 11:34-41. 28. Rahmani R, Zarrini G, Sheikhzadeh F, Aghamohammadzadeh N. Effective phages as green antimicrobial agents against antibiotic resistant hospital Escherichia coli Jundishapur J Microbiol 2015; 8:59808. doi.10.5812/jjm.17744. doi.10.5812/jjm.17744. 29. Hosainzadegan H, Mohammadi M, Pajohy N, Ebrahimzade F. Study of lytic phage and alkaline phosphatase on treatment of burn infections caused by Escherichia coli in MouseIran J Med Microbiol 2008; 2:37-43. 30. Servick K. Beleaguered phage therapy trial presses on. Science 2016; 352:1506. doi.10.1126/science.
|
